EINEN GENETISCH MODIFIZIERTEN ANTIKÖRPER GEGEN CHEMOKIN-REZEPTOR-CCR4 ENTHALTENDES MEDIKAMENT

摘要

A medicament having a higher therapeutic effect than that provided by administration of a recombinant antibody against human CC chemokine receptor 4 or an antibody fragment thereof or an agent alone is provided.